It's Time to Improve Methods for Breast-Cancer Detection

It has been more than six years since I was first diagnosed with breast cancer at age 35. Since then, my life has changed in more ways than I could have imagined. I became an activist, founding a nonprofit advocacy organization for Latin American women with breast cancer. And I learned that I am by no means alone. Each year, more than 180,000 new cases of invasive breast cancer are diagnosed and more than 40,000 women die from it. Breast cancer is still a leading cause of cancer death in this co

Written byCarolina Hinestrosa
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I also learned a lot about what is needed to fight this disease. One of the most obvious areas for improvement is in breast-cancer detection. Since the 1970s, X-ray film mammography has been the main tool for breast-cancer screening. And indeed, mammography has contributed to a reduction in mortality from breast cancer. But it also has many serious limitations. X-ray mammography does not detect all cancers, including some that are picked up by physical examination. Mammograms are particularly difficult to interpret for women with dense breast tissue, which is especially common in younger women. In addition, some tumors may develop too quickly to be identified at the most treatable stage by using annual screening mammograms.

And because there is still limited understanding of the biology and progression of breast cancer, mammograms can sometimes lead to more questions than answers. For example, as many as three-quarters of all breast lesions that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies